Related Experiment Videos
Transesophageal echocardiography and stroke.
1Cardiology Section, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA. twoods@mcw.edu
Current Atherosclerosis Reports
|June 25, 2005
Summary
Transesophageal echocardiography (TEE) aids in diagnosing stroke causes by revealing cardiac issues like atrial septal aneurysm and patent foramen ovale. However, clinical trial evidence varies for different cardiac pathologies, impacting treatment decisions.
Area of Science:
- Cardiology
- Neurology
- Medical Imaging
Background:
- Stroke is a leading cause of death in the US, necessitating accurate etiological diagnosis.
- Transesophageal echocardiography (TEE) is a cardiac ultrasound technique offering detailed anatomic and functional information.
- Identifying cardiac sources of embolism is a common, yet complex, indication for TEE.
Purpose of the Study:
- To evaluate the role of TEE in diagnosing stroke etiologies.
- To highlight TEE's sensitivity in detecting specific cardiac abnormalities linked to embolism.
- To emphasize the need for critical assessment of evidence supporting TEE findings in stroke workup.
Main Methods:
- Review of literature on transesophageal echocardiography for stroke cause identification.
- Analysis of TEE's efficacy in detecting atrial septal aneurysm, patent foramen ovale, and aortic atheroma.
- Consideration of the evidence base for various cardiac pathologies as embolic sources.
Main Results:
- TEE offers superior detail for cardiac anatomy and function relevant to cerebral ischemia.
- TEE demonstrates higher sensitivity than transthoracic imaging for detecting atrial septal aneurysm, patent foramen ovale, and aortic atheroma.
- The clinical validation and evidence strength for TEE-identified embolic sources vary significantly.
Conclusions:
- TEE is a valuable tool in the stroke workup for identifying potential cardiac sources of embolism.
- Careful interpretation of TEE findings is crucial, considering the varying levels of clinical evidence.
- Therapeutic decisions should integrate the confidence in the cause-and-effect relationship of identified cardiac pathologies.